Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Dutasteride may become the top choice for treating hair loss.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Baricitinib is the most effective treatment for alopecia areata.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Baricitinib is effective for severe alopecia areata but has some side effects.

The new gel for hair loss is safe, effective, and reduces side effects.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Baricitinib is effective as a treatment for severe hair loss.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.